Bone Conduction Implantable Devices Program
Bone conduction implantable devices are used in cases of conductive hearing loss, mixed hearing loss and single sided deafness, when conventional hearing aids do not provide sufficient access to sound or are contraindicated due to anatomical or chronic middle ear conditions.
NSW Health has partnered with SCIC Cochlear Implant Program, an RIDBC service, with a funding contribution of $1.071 million until 30 June 2019 towards a BCID pilot in public hospitals which will help treat adults in NSW suffering from conductive hearing loss to improve their quality of life.
For more information around the establishment and funding of the pilot program read our FAQs for Healthcare Professionals document.
Clinical Document Downloads:
- BCID Program Policy & Procedures
- BCID Assessment Sheet
- BCID Participation Agreement
- Categories of Auditory Performance (CAP)
- Speech Spatial Qualities (SSQ)
- Speech Spatial Qualities -C (SSQ-C)
- FAQs for Healthcare Professionals